News | June 08, 2024
Briefs: Concord Biotech and Shelter Pharma
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Shelter Pharma Limited secured an order from Berlin International Medical Co D3Cure 50 ml x 30000 pcs
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
The drug will be manufactured at the group's topical manufacturing facility at Changodar, Ahmedabad (India)
Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
The inspection was concluded with few procedural observations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
